Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
2003 3
2004 1
2005 3
2006 1
2007 1
2014 1
2016 2
2019 1
2021 2
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
From pyrroles to pyrrolo[1,2-a]pyrazinones: a new class of mGluR1 antagonists.
Micheli F, Cavanni P, Di Fabio R, Marchioro C, Donati D, Faedo S, Maffeis M, Sabbatini FM, Tranquillini ME. Micheli F, et al. Among authors: maffeis m. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1342-5. doi: 10.1016/j.bmcl.2005.11.049. Epub 2005 Dec 5. Bioorg Med Chem Lett. 2006. PMID: 16337118
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey).
Russo D, Polverelli N, Malagola M, Farina M, Leoni A, Bernardi S, Mammoliti S, Sacchi N, Martino M, Ciceri F; GITMO Centers. Russo D, et al. Bone Marrow Transplant. 2021 Sep;56(9):2272-2275. doi: 10.1038/s41409-021-01287-w. Epub 2021 Apr 19. Bone Marrow Transplant. 2021. PMID: 33875810 Free PMC article.
Synthesis and pharmacological characterisation of 2,4-dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists.
Micheli F, Fabio RD, Cavanni P, Rimland JM, Capelli AM, Chiamulera C, Corsi M, Corti C, Donati D, Feriani A, Ferraguti F, Maffeis M, Missio A, Ratti E, Paio A, Pachera R, Quartaroli M, Reggiani A, Sabbatini FM, Trist DG, Ugolini A, Vitulli G. Micheli F, et al. Among authors: maffeis m. Bioorg Med Chem. 2003 Jan 17;11(2):171-83. doi: 10.1016/s0968-0896(02)00424-8. Bioorg Med Chem. 2003. PMID: 12470711
CD34+ Stem Cell Selection and CD3+ T Cell Add-Back from Matched Unrelated Adult Donors in Children with Primary Immunodeficiencies and Hematological Diseases.
Porta F, Comini M, Soncini E, Carracchia G, Maffeis M, Pintabona V, Bolda F, Beghin A, Schumacher RF, Lanfranchi A. Porta F, et al. Among authors: maffeis m. Transplant Cell Ther. 2021 May;27(5):426.e1-426.e9. doi: 10.1016/j.jtct.2021.01.020. Epub 2021 Jan 24. Transplant Cell Ther. 2021. PMID: 33965183 Free article.
Acral lympho-histiocytic dermatitis in X-linked agammaglobulinemia: a case report showing clonal CD8(+) T cells with indolent clinical behaviour.
Gualdi G, Lorenzi L, Arisi M, Maffeis M, Soresina A, Marocolo D, Plebani A, Calzavara-Pinton PG, Facchetti F. Gualdi G, et al. Among authors: maffeis m. J Eur Acad Dermatol Venereol. 2016 Mar;30(3):461-3. doi: 10.1111/jdv.12839. Epub 2014 Nov 11. J Eur Acad Dermatol Venereol. 2016. PMID: 25388899 No abstract available.
15 results